Apyx Medical Corp — Director's Dealing 2019

Feb 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2019-01-09

Reporting Person: Goodwin Charles D. II (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-09	Stock Option (Option to Buy)	$7.91	A	236000	Acquired	2029-01-09	Common Stock (236000.0)	Direct

Footnotes

F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.